Clotrimazole 1 % / betamethasone dipropionate 0.05 % Topical Lotion
RxNorm 308715
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 308715 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: clotrimazole 1 % / betamethasone dipropionate 0.05 % Topical Lotion.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Betamethasone 0.5 mg/ML / clotrimazole 10 mg/ML Topical Lotion
(Atom ID: 12340324)
SYPrescribable
Synonym (SY):
Betamethasone 0.05 % (betamethasone dipropionate 0.064 % ) / clotrimazole 1 % Topical Lotion
(Atom ID: 12709675)
PSNPrescribable
Prescribable Name (PSN):
Clotrimazole 1 % / betamethasone dipropionate 0.05 % Topical Lotion
(Atom ID: 6799693)
Patient Education
Betamethasone Topical
Betamethasone topical is used to treat the itching, redness, dryness, crusting, scaling, inflammation, and discomfort of various skin conditions, including psoriasis (a skin disease in which red, scaly patches form on some areas of the body) and eczema (a skin disease that causes the skin to be dry and itchy and to sometimes develop red, scaly rashes). Betamethasone is in a class of medications called corticosteroids. It works by activating natural substances in the skin to reduce swelling, redness, and itching.
[Learn More]
Clotrimazole Vaginal
Vaginal clotrimazole is used to treat vaginal yeast infections in adults and children 12 years of age and older.. Clotrimazole is in a class of antifungal medications called imidazoles. It works by stopping the growth of fungi that cause infection.
[Learn More]
* Please review the disclaimer below.